Daniel Jasserand

Title: The Innovations of Daniel Jasserand

Introduction

Daniel Jasserand is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with human ORL1 receptors. His work is characterized by a focus on innovative solutions for medical treatments.

Latest Patents

One of Daniel Jasserand's key patents is titled "Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors." This invention relates to a group of hydronopol substituted benzimidazolone and quinazolinone derivatives that act as agonists on human ORL1 (nociceptin) receptors. The patent also covers the preparation of these compounds, pharmaceutical compositions containing a pharmacologically active amount of at least one of these novel derivatives, and their use in treating disorders involving ORL1 receptors. The compounds are defined by a general formula, with specific symbols detailed in the patent description.

Career Highlights

Daniel Jasserand is currently associated with Solvay Pharmaceuticals B.V., where he continues to advance his research and development efforts. His work has led to the creation of innovative pharmaceutical solutions that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Daniel has collaborated with notable colleagues, including Jacobus A J Den Hartog and Samuel David. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Daniel Jasserand's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.